Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
about
Cerebrospinal fluid and blood biomarkers in Alzheimer's diseaseSolvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.CSF biomarkers for mild cognitive impairment.Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?Total and phosphorylated tau protein as biological markers of Alzheimer's disease.Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.Cerebrospinal fluid analysis should be considered in patients with cognitive problemsApplying new research criteria for diagnosis of early Alzheimer's disease: sex and intelligence matter.Biological markers and Alzheimer disease: a canadian perspectiveBrain atrophy in healthy aging is related to CSF levels of Aβ1-42.An overview of biomarkers in Alzheimer's disease.In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.Emerging biomarkers in cognition.Biomarkers in Alzheimer's disease.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's diseaseCerebrospinal fluid markers in sporadic Creutzfeldt-Jakob diseaseCSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases.Elevated cerebrospinal fluid tau in Wernicke encephalopathy.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratoryRaised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.Detection of brain injury by fatty acid-binding proteins.How proteomics reveals potential biomarkers in brain diseases.Sensitive quantitative assays for tau and phospho-tau in transgenic mouse modelsNeurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?Current state and future directions of neurochemical biomarkers for Alzheimer's disease.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis
P2860
Q27023758-3C648FC5-924F-4E27-8C64-17B681700B2DQ30381260-4B523793-9075-4502-9897-94D81EE8983DQ30845482-CA44A8EE-1B1E-409D-AB4E-DBA1F2FF4B26Q30953185-FE4D22B4-E9FF-4CEF-A1D5-0165273454ECQ33258308-FBDADF50-D920-4C32-977E-5A8B2E747E83Q33624674-1A0F2ED4-C19B-4924-B178-0BC6AC542E45Q33924646-773CC110-5956-4F81-AB9F-6976F0CBEE7FQ34026659-386D47EB-F3E3-4833-A742-63774C99A7EEQ34077530-12D1C299-46E6-4910-9AED-18D146BCDFE4Q34089784-47B27C0E-7769-44F4-9DA8-46FDBC53E878Q34514638-0C0A419A-90C3-4AA4-88F6-A9BBF2CA1160Q34574944-69E49576-1BC3-4B34-A6B0-613B0E44FDDEQ34985153-682F5281-CA28-4D2A-A33C-EE69CC9A12E8Q35008258-644D189F-FAF4-4CFD-9106-71263584864FQ35113795-5441A3F8-A0F8-46CF-B2FB-58A6520EF8C9Q35236838-0E25A4AA-08B6-4BB9-9322-CECB8F5AF19FQ35284971-D7E77919-EE5E-4E5C-9105-EE16BA6CD1E0Q35297556-FD9DD681-B9C5-47E8-BB0F-A80BFD4597FEQ35580179-E9A6B03B-3DDC-4DB0-8B33-4A897389E62AQ35744444-0727D30B-7CF6-4947-B6BF-A1C38AAA65EFQ35750755-1CEA4577-D773-4D40-AA0C-99E4625E4E0FQ35859244-9A9D90BB-EBB7-4C8F-B1FC-927B8F6DB519Q35979240-1A8DD2C2-DE7B-455D-90BC-A5E0FC9245A6Q36045282-B20BDE62-7581-4223-9CFF-926E1E2B1DFAQ36134872-DEBF21F0-9432-475D-AB5F-00DE1BC071CCQ36216862-2E1C7800-96D3-433C-A612-20BCA62247DBQ36226169-15DA8BFC-411E-4F33-97BD-B14099588F76Q36252166-6922D49C-6F09-4B2C-9153-C614786D1250Q36275438-C3CEE99C-6543-4DD1-B133-F05FF1DC0E3CQ36322155-2A134724-7EE0-444A-8441-3E07BA9BBAB9Q36328476-E3C066E1-706F-4115-BDE8-F9332A51C7D1Q36412490-431ABD4B-24E2-41FC-B8D5-DEA541812A65Q36439886-627C4459-E664-4D8D-A434-C3F06AE682CDQ36796560-FAAF9F6A-9041-4965-BC2E-B0F79E2E0129Q36865663-D4D04120-9DC8-4FA1-B3F8-2332E1E8310BQ36939128-003F249E-E187-4812-88EC-743AE983D0BFQ36985933-A7071141-439E-4255-A2AF-84CBEBAAF170Q37068847-8B65541E-122F-4E6C-9EB4-DA09378B3C95Q37206262-394606D3-0174-470A-BE37-B0AFA46D4D48Q37213414-D5253BBE-329D-4643-8D54-6F85BEA349CE
P2860
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Phospho-tau/total tau ratio in ...... disease from other dementias.
@en
Phospho-tau/total tau ratio in ...... disease from other dementias.
@nl
type
label
Phospho-tau/total tau ratio in ...... disease from other dementias.
@en
Phospho-tau/total tau ratio in ...... disease from other dementias.
@nl
prefLabel
Phospho-tau/total tau ratio in ...... disease from other dementias.
@en
Phospho-tau/total tau ratio in ...... disease from other dementias.
@nl
P2093
P356
P1433
P1476
Phospho-tau/total tau ratio in ...... disease from other dementias.
@en
P2093
Kretzschmar H
Riemenschneider M
Vanderstichele H
Wagenpfeil S
P2888
P304
P356
10.1038/SJ.MP.4001220
P407
P577
2003-03-01T00:00:00Z